ACOG (Alpha Cognition) Moat Score: 2/10 (As of Jun. 25, 2026)


ACOG Alpha Cognition Inc ACOG
32 GF Score
Price $6.62
! 3 Warning Signs
View Full Analysis

What is Alpha Cognition Moat Score?

Alpha Cognition ACOG +0.46% 32 Moat Score is 2 as of Jun. 25, 2026. GuruFocus rates ACOG with a GF Score™ of 32/100. The stock has 3 warning signs investors should review. Among 1,405 Biotechnology companies, Alpha Cognition ranks better than 58.15% on this metric.

Alpha Cognition has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Alpha Cognition has No Moat: Alpha Cognition Inc has transient advantages with limited market share and no significant intellectual property or regulatory barriers. The company lacks strong brand strength and customer loyalty, making its competitive position weak.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Alpha Cognition might have No Moat - Very weak/transient advantages.

Alpha Cognition  (NAS:ACOG) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Alpha Cognition Moat Score Related Terms

ACOG vs GNLX, VTVT, CRDF: Moat Score Comparison

For the Biotechnology subindustry, Alpha Cognition's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alpha Cognition Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Cognition's Moat Score distribution charts can be found below:

* The bar in red indicates where Alpha Cognition's Moat Score falls into.


ACOG
32GF Score
Alpha Cognition Inc ACOG
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Alpha Cognition (ACOG) has a Moat Score of 2 as of Jun. 25, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Alpha Cognition ranks #588 out of 1405 companies in the Biotechnology industry, placing it in the top 41.9%.
Is Alpha Cognition's Moat Score too high?
Alpha Cognition's current Moat Score is 2. The Biotechnology industry median Moat Score is 2.00. Alpha Cognition's value of 2 is 0% at this industry median. Based on the distribution chart, Alpha Cognition ranks #588 out of 1405 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Alpha Cognition has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Alpha Cognition's Moat Score compare to GNLX and VTVT?
According to the Biotechnology industry distribution chart, Alpha Cognition ranks #588 out of 1405 companies for Moat Score. This puts Alpha Cognition in the upper half of its industry. The industry median Moat Score is 2.00. Alpha Cognition's value of 2 is 0% at this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,405 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alpha Cognition's current Moat Score of 2 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alpha Cognition's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Cognition stock overvalued right now?
Alpha Cognition (ACOG) has a current Moat Score of 2. The current Moat Score is 2 and 0% at the Biotechnology industry median of 2.00. Alpha Cognition's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Alpha Cognition (ACOG), the current Moat Score is 2 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alpha Cognition Business Description

Other Exchanges 7N70:Germany
Address 1200 - 750 West Pender Street, Vancouver, BC, CAN, V6C 2T8
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
32GF Score

Get the complete analysis for ACOG

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.62
Price